Login to Your Account



Pharma: Other News To Note


Monday, April 2, 2012
• HTG Molecular Diagnostics, of Tucson, Ariz. established a collaborative program with Bridgewater, N.J.- based Sanofi US, part of Sanofi SA, to identify biomarkers that may lead to the development of a molecular companion diagnostic test to help identify patients most likely to respond to an unidentified Sanofi investigational agent.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription